|
Market Cap | 16.77M | EPS (ttm) | -1.00 |
P/E | - | EPS this Y | 22.95% |
Forward P/E | - | EPS next Y | 40.71% |
PEG | - | EPS past 5Y | 0.80% |
P/S | 0.56 | EPS next 5Y | - |
P/B | 0.40 | EPS Q/Q | -11.97% |
Dividend | - | Sales Q/Q | 2.09% |
Insider Own | 5.49% | Inst Own | 41.32% |
Insider Trans | 38.05% | Inst Trans | -2.20% |
Short Float | 10.69% | Earnings | May 13/b |
Analyst Recom | 1.80 | Target Price | 1.35 |
Avg Volume | 656.87K | 52W Range | 0.35 - 3.57 |
|
|
|
Akoustis Technologies, Inc. is a filter solutions company, which engages in the development, design, and manufacture of radio frequency (RF) filter products. It operates through the Foundry Fabrication Services and RF Filters segments. The Foundry Fabrication Services segment is composed of engineering review services and STC-MEMS foundry services. The RF Filters segment includes amplifier and filter product sales, and grant revenue. The company was founded by Jeffrey B. Shealy in 2014 and is headquartered in Huntersville, NC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Shealy Jeffrey B. | Chief Executive Officer | Jan 29 '24 | Buy | 0.50 | 1,310,000 | 655,000 | 2,222,775 | Jan 31 06:39 PM | Aichele David | EVP of Business Development | Jan 29 '24 | Buy | 0.50 | 80,000 | 40,000 | 334,622 | Jan 31 06:39 PM | Boller Kenneth | CFO | Jan 29 '24 | Buy | 0.50 | 60,000 | 30,000 | 214,957 | Jan 31 06:39 PM | Geiss Arthur | Director | Jan 29 '24 | Buy | 0.50 | 50,000 | 25,000 | 415,924 | Jan 31 06:40 PM | Aichele David | EVP of Business Development | Dec 18 '23 | Sale | 0.72 | 1,500 | 1,083 | 254,622 | Dec 20 05:03 PM |
|
|
|
|
Market Cap | 3.70M | EPS (ttm) | -0.27 |
P/E | - | EPS this Y | 3.57% |
Forward P/E | - | EPS next Y | 22.22% |
PEG | - | EPS past 5Y | -2.02% |
P/S | - | EPS next 5Y | - |
P/B | 1.40 | EPS Q/Q | 19.08% |
Dividend | - | Sales Q/Q | - |
Insider Own | 22.83% | Inst Own | 3.52% |
Insider Trans | 0.00% | Inst Trans | 155.58% |
Short Float | 1.61% | Earnings | May 09/b |
Analyst Recom | 3.00 | Target Price | 0.40 |
Avg Volume | 309.98K | 52W Range | 0.28 - 2.42 |
|
|
|
Virios Therapeutics, Inc. engages in pharmaceutical products for fibromyalgia and other related conditions. The firm engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. It offers IMC-1, a novel, proprietary, fixed dose combination of famciclovir and celecoxib. The company was founded by William L. Pridgen on February 28, 2012 and is headquartered in Alpharetta, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Pridgen William | Director | Aug 21 '23 | Buy | 1.30 | 15,335 | 19,992 | 52,045 | Aug 22 03:57 PM | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | Aug 17 '23 | Buy | 1.25 | 25,000 | 31,245 | 57,461 | Aug 18 07:05 AM |
|
|
|
|
Market Cap | 11.74M | EPS (ttm) | -2.69 |
P/E | - | EPS this Y | 34.05% |
Forward P/E | - | EPS next Y | 12.90% |
PEG | - | EPS past 5Y | - |
P/S | 0.75 | EPS next 5Y | - |
P/B | 0.29 | EPS Q/Q | 43.65% |
Dividend | - | Sales Q/Q | 10.58% |
Insider Own | 11.91% | Inst Own | 13.01% |
Insider Trans | -0.38% | Inst Trans | -24.11% |
Short Float | 10.05% | Earnings | May 14/a |
Analyst Recom | 2.20 | Target Price | 2.28 |
Avg Volume | 298.92K | 52W Range | 0.49 - 3.90 |
|
|
|
DermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Its products and services include melanoma test, smart sticker, and telemedicine option for melanoma test. The company was founded in 1995 and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Sun Kevin M | Chief Financial Officer | Dec 11 '23 | Sale | 1.45 | 447 | 648 | 277,499 | Dec 11 08:02 PM | Ibarra Claudia | Chief Operating Officer | Dec 11 '23 | Sale | 1.45 | 331 | 480 | 193,547 | Dec 11 08:02 PM | Ibarra Claudia | Chief Operating Officer | Dec 08 '23 | Sale | 1.41 | 2,607 | 3,676 | 193,878 | Dec 11 08:02 PM | Sun Kevin M | Chief Financial Officer | Dec 07 '23 | Sale | 1.53 | 4,979 | 7,618 | 277,946 | Dec 11 08:02 PM | Ibarra Claudia | Chief Operating Officer | Dec 07 '23 | Sale | 1.53 | 3,911 | 5,984 | 196,485 | Dec 11 08:02 PM |
|
|
| |
|
Market Cap | 12.10M | EPS (ttm) | -584.47 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 92.88% |
P/S | 0.97 | EPS next 5Y | 20.00% |
P/B | 0.13 | EPS Q/Q | 99.98% |
Dividend | - | Sales Q/Q | -51.74% |
Insider Own | 29.39% | Inst Own | 3.23% |
Insider Trans | 0.00% | Inst Trans | 0.23% |
Short Float | 1.36% | Earnings | - |
Analyst Recom | 3.00 | Target Price | 0.25 |
Avg Volume | 1.66M | 52W Range | 1.53 - 39.80 |
|
|
|
XTI Aerospace, Inc. engages in the provision of aircraft manufacturing. It primarily focuses on the light and mid-size business aircraft market. The company was founded in April 1999 and is headquartered in Englewood, CO. |
|
|
|
Market Cap | 13.62M | EPS (ttm) | 0.23 |
P/E | 2.21 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -421.29% |
Dividend | - | Sales Q/Q | - |
Insider Own | 63.01% | Inst Own | 0.57% |
Insider Trans | 0.00% | Inst Trans | 6.99% |
Short Float | 0.31% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 183.80K | 52W Range | 0.65 - 11.55 |
|
|
|
Nature's Miracle Holding Inc. is an agriculture technology company, which engages in the provision of CEA hardware products to growers in the controlled environment agriculture industry setting in North America. The company is headquartered in Upland, CA. |
|
| |
|
Market Cap | 3.86M | EPS (ttm) | -42.50 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 55.29% |
P/S | 0.25 | EPS next 5Y | - |
P/B | 1.58 | EPS Q/Q | 98.29% |
Dividend | - | Sales Q/Q | -17.36% |
Insider Own | 0.04% | Inst Own | 0.15% |
Insider Trans | 0.00% | Inst Trans | -46.90% |
Short Float | 1.00% | Earnings | May 20/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 81.27K | 52W Range | 2.26 - 26.50 |
|
|
|
Digital Brands Group, Inc. engages in the manufacture and sale of apparel. Its portfolio brands include Bailey 44, DSTLD, Harper and Jones, Stateside, and Sundry. The company was founded by Corey Epstein, Mark T. Lynn, and Kevin Morris on September 17, 2012 and is headquartered in Austin, TX. |
|
|
|
Market Cap | 8.64M | EPS (ttm) | -0.37 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 42.73% |
P/S | 1.16 | EPS next 5Y | - |
P/B | 3.63 | EPS Q/Q | 35.33% |
Dividend | - | Sales Q/Q | -11.68% |
Insider Own | 50.39% | Inst Own | 2.52% |
Insider Trans | 0.00% | Inst Trans | 1.10% |
Short Float | 0.70% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 4.50 |
Avg Volume | 74.38K | 52W Range | 0.86 - 5.00 |
|
|
May-15-24 09:55PM
|
IPDN Stock Earnings: Professional Diversity Reported Results for Q1 2024
(InvestorPlace) |
09:10AM
|
Professional Diversity Network, Inc. Announces Financial Results for the Quarter Ended March 31, 2024
(GlobeNewswire) |
Mar-29-24 09:00AM
|
Professional Diversity Network, Inc. Announces Financial Results for the Quarter and Fiscal Year Ended December 31, 2023
(GlobeNewswire) |
Mar-25-24 09:10AM
|
Professional Diversity Network (PDN) Hosts Successful Virtual Career Fair for Women's History Month
(GlobeNewswire) +12.61% |
Feb-22-24 09:00AM
|
Professional Diversity Network (PDN) Hosts Successful Virtual Career Fair for National Urban League (NUL), Celebrating Black History Month
(GlobeNewswire) |
Nov-14-23 01:40PM
|
Professional Diversity Network, Inc. Announces Financial Results for the Quarter Ended September 30, 2023
(GlobeNewswire) |
Aug-14-23 04:58PM
|
Professional Diversity Network, Inc. Announces Financial Results for the Quarter Ended June 30, 2023
(GlobeNewswire) |
Jun-30-23 04:00PM
|
Professional Diversity Network Announces Committed Equity Line
(GlobeNewswire) |
Jun-22-23 09:00AM
|
Professional Diversity Network Inc. Hosts Successful Happy Hour Hiring Event
(GlobeNewswire) |
May-15-23 03:08PM
|
Professional Diversity Network, Inc. Announces Financial Results for the Quarter Ended March 31, 2023
(GlobeNewswire) |
|
Professional Diversity Network, Inc. operates online and in-person networks that provide access to networking, training, educational and employment opportunities for diverse professionals. It operates through four segments: Professional Diversity Network (PDN Network), National Association of Professional Women (NAPW Network), RemoteMore, and Corporate Overhead. The PDN Network segment consists of online professional networking communities with career resources tailored to the needs of various cultural groups. The NAPW Network segment refers to women-only professional networking organization. The RemoteMore segment connects companies with developers with less effort and friction, and software developers to get jobs regardless of their location. The Corporate Overhead refers to operating expenses. The company was founded by Rudy Martinez on October 3, 2003 and is headquartered in Chicago, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Chou Yu-Jin | Secretary | Jun 07 '23 | Sale | 4.30 | 1,834 | 7,886 | 0 | Jun 08 05:28 PM | Chou Yu-Jin | Secretary | Jun 06 '23 | Sale | 3.50 | 1,500 | 5,250 | 1,834 | Jun 08 05:28 PM | Chou Yu-Jin | Secretary | Jun 02 '23 | Sale | 3.00 | 1,500 | 4,500 | 3,334 | Jun 02 04:26 PM | Chou Yu-Jin | Secretary | May 31 '23 | Sale | 3.80 | 2,000 | 7,600 | 4,834 | Jun 02 04:26 PM | Chou Yu-Jin | Secretary | May 30 '23 | Sale | 4.00 | 857 | 3,428 | 6,834 | May 30 07:18 PM |
|
|
| |
|
Market Cap | 11.04M | EPS (ttm) | -599.49 |
P/E | - | EPS this Y | 98.73% |
Forward P/E | - | EPS next Y | 40.00% |
PEG | - | EPS past 5Y | 57.56% |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | 99.34% |
Dividend | - | Sales Q/Q | - |
Insider Own | 6.95% | Inst Own | 0.02% |
Insider Trans | 0.00% | Inst Trans | -16.93% |
Short Float | 1.35% | Earnings | May 14/a |
Analyst Recom | 1.00 | Target Price | 8.00 |
Avg Volume | 3.30M | 52W Range | 0.63 - 283.20 |
|
|
|
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA. |
|
|
|
Market Cap | 12.14M | EPS (ttm) | -0.94 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.18 | EPS next 5Y | - |
P/B | 0.28 | EPS Q/Q | 57.35% |
Dividend | - | Sales Q/Q | 12.20% |
Insider Own | 38.31% | Inst Own | 31.17% |
Insider Trans | 0.00% | Inst Trans | 9.44% |
Short Float | 0.12% | Earnings | - |
Analyst Recom | 3.00 | Target Price | 24.00 |
Avg Volume | 1.82K | 52W Range | 3.20 - 10.06 |
|
|
|
Patriot National Bancorp, Inc. operates as a bank holding company. The firm offers consumer and commercial deposit accounts, such as checking, interest-bearing negotiable order of withdrawal, money market, savings, prepaid deposit, online national money market, individual retirement accounts, and health savings accounts, as well as certificate of deposit account registry services. Its loan portfolio consists of commercial real estate, commercial business, SBA, construction, purchased residential real estate, and various consumer loans. The company also offers automated clearing house transfers, lockbox, Internet banking, bill payment, remote deposit capture, debit cards, money orders, traveler's checks, and automatic teller machine services. The company was founded in 1999 and is headquartered in Stamford, CT. |
|
|
|
Market Cap | 2.17M | EPS (ttm) | -17.21 |
P/E | - | EPS this Y | 46.05% |
Forward P/E | - | EPS next Y | 69.57% |
PEG | - | EPS past 5Y | 45.52% |
P/S | 0.39 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -682.38% |
Dividend | - | Sales Q/Q | -78.91% |
Insider Own | 10.62% | Inst Own | 19.05% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 3.61% | Earnings | May 10/a |
Analyst Recom | 2.00 | Target Price | 7.00 |
Avg Volume | 58.41K | 52W Range | 2.50 - 37.20 |
|
|
|
Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY. |
|
|